ATOSSA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ATOSSA THERAPEUTICS, INC. (ATOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 63.33 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 63.33K shares, a 52.95% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was -4.03M shares, a 917.97% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 344.55K shares, a 92.67% decline from fiscal 2024.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 4.70M shares, a 31.15% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 6.83M shares, a 67.41% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.08M shares, a 6.81% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 63.33K shares 10-Q · filed 2026-08-07 | -3.97M shares derived: sum of 3 quarters · filed 2026-08-07 | -3.97M shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 63.33K shares 10-Q · filed 2026-05-08 | -3.97M shares derived: sum of 2 quarters · filed 2026-05-08 | -3.97M shares derived: sum of 3 quarters · filed 2026-05-08 | 273.28K shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | -4.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -4.03M shares derived: sum of 2 quarters · filed 2026-03-25 | 209.95K shares derived: sum of 3 quarters · filed 2026-03-25 | 344.55K shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 4.24M shares derived: sum of 2 quarters · filed 2025-11-12 | 4.38M shares 10-Q · filed 2025-11-12 | 4.87M shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 4.24M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 4.38M shares 10-Q · filed 2025-08-12 | 4.87M shares derived: sum of 3 quarters · filed 2025-08-12 | 4.87M shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 134.60K shares 10-Q · filed 2025-05-13 | 627.60K shares derived: sum of 2 quarters · filed 2025-05-13 | 627.60K shares derived: sum of 3 quarters · filed 2025-05-13 | 4.69M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 493.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 493.00K shares derived: sum of 2 quarters · filed 2025-03-25 | 4.56M shares derived: sum of 3 quarters · filed 2025-03-25 | 4.70M shares 10-K · filed 2025-03-25 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 4.06M shares derived: sum of 2 quarters · filed 2024-11-12 | 4.21M shares 10-Q · filed 2024-11-12 | 4.35M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 4.06M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 4.21M shares 10-Q · filed 2024-08-12 | 4.35M shares derived: sum of 3 quarters · filed 2024-08-12 | 4.35M shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 145.83K shares 10-Q · filed 2024-05-13 | 283.43K shares derived: sum of 2 quarters · filed 2024-05-13 | 283.43K shares derived: sum of 3 quarters · filed 2024-05-13 | 4.51M shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 137.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 137.60K shares derived: sum of 2 quarters · filed 2024-04-01 | 4.37M shares derived: sum of 3 quarters · filed 2024-04-01 | 6.83M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 4.23M shares derived: sum of 2 quarters · filed 2023-11-13 | 6.69M shares 10-Q · filed 2023-11-13 | 6.89M shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 4.23M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 6.69M shares 10-Q · filed 2023-08-14 | 6.89M shares derived: sum of 3 quarters · filed 2023-08-14 | 6.92M shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 2.46M shares 10-Q · filed 2023-05-15 | 2.66M shares derived: sum of 2 quarters · filed 2023-05-15 | 2.69M shares derived: sum of 3 quarters · filed 2023-05-15 | 3.82M shares derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | 200.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 230.00K shares derived: sum of 2 quarters · filed 2023-03-22 | 1.36M shares derived: sum of 3 quarters · filed 2023-03-22 | 4.08M shares 10-K · filed 2023-03-22 |
| 2022-09-30 | 30.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 1.16M shares derived: sum of 2 quarters · filed 2022-11-07 | 3.88M shares 10-Q · filed 2022-11-07 | 3.88M shares derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | 1.13M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 3.85M shares 10-Q · filed 2022-08-08 | 3.85M shares derived: sum of 3 quarters · filed 2022-08-08 | 4.02M shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 2.72M shares 10-Q · filed 2022-05-09 | 2.72M shares derived: sum of 2 quarters · filed 2022-05-09 | 2.90M shares derived: sum of 3 quarters · filed 2022-05-09 | 6.54M shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 79.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 175.08K shares derived: sum of 2 quarters · filed 2022-02-28 | 3.82M shares derived: sum of 3 quarters · filed 2022-02-28 | 3.82M shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 175.00K shares 10-Q · filed 2021-11-15 | 3.82M shares derived: sum of 2 quarters · filed 2021-11-15 | 3.82M shares 10-Q · filed 2021-11-15 | 3.82M shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-06-30 | 3.64M shares 10-Q · filed 2021-08-13 | 3.64M shares 10-Q · filed 2021-08-13 | 3.64M shares derived: sum of 3 quarters · filed 2022-02-28 | 3.87M shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-03-31 | 0.00 shares derived: 10-K 12 month − 3 quarters · filed 2022-02-28 | 0.00 shares derived: sum of 2 quarters · filed 2022-02-28 | 225.00K shares derived: sum of 3 quarters · filed 2022-02-28 | 3.14M shares derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 225.00K shares derived: sum of 2 quarters · filed 2021-11-15 | 3.14M shares derived: sum of 3 quarters · filed 2021-11-15 | 3.14M shares 10-K · filed 2021-03-31 |
| 2020-09-30 | 225.00K shares 10-Q · filed 2021-11-15 | 3.14M shares derived: sum of 2 quarters · filed 2021-11-15 | 3.14M shares 10-Q · filed 2021-11-15 | |
| 2020-06-30 | 2.92M shares 10-Q · filed 2021-08-13 | 2.92M shares 10-Q · filed 2021-08-13 | ||
| 2019-09-30 | 3.56M shares 10-Q · filed 2019-11-13 | |||
| 2018-06-30 | 610.00K shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-11-13 | 611.67K shares 10-Q/A · filed 2018-11-13 | 611.67K shares derived: sum of 3 quarters · filed 2018-11-13 | 611.67K shares derived: sum of 4 quarters · filed 2018-11-13 |
| 2018-03-31 | 1.67K shares 10-Q · filed 2018-05-14 | 1.67K shares derived: sum of 2 quarters · filed 2018-05-14 | 1.67K shares derived: sum of 3 quarters · filed 2018-05-14 | 1.71M shares derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-08 | 1.71M shares derived: sum of 3 quarters · filed 2018-03-08 | 1.72M shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 0.00 shares 10-Q · filed 2017-11-13 | 1.71M shares derived: sum of 2 quarters · filed 2017-11-13 | 1.72M shares 10-Q · filed 2017-11-13 | 1.72M shares derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | 1.71M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 1.72M shares 10-Q · filed 2017-08-14 | 1.72M shares derived: sum of 3 quarters · filed 2017-08-14 | -877.10K shares derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | 5.00K shares 10-Q · filed 2017-05-11 | 5.00K shares derived: sum of 2 quarters · filed 2017-05-11 | -2.59M shares derived: sum of 3 quarters · filed 2017-05-11 | 190.25K shares derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | -2.59M shares derived: sum of 2 quarters · filed 2017-03-21 | 185.25K shares derived: sum of 3 quarters · filed 2017-03-21 | 185.25K shares 10-K/A · filed 2017-03-21 |
| 2016-09-30 | -2.59M shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | 185.25K shares derived: sum of 2 quarters · filed 2017-03-21 | 185.25K shares 10-Q/A · filed 2017-03-21 | 390.25K shares derived: sum of 4 quarters · filed 2017-03-21 |
| 2016-06-30 | 2.78M shares derived: 10-Q/A 6 month − 10-Q 3 month · filed 2017-03-21 | 2.78M shares 10-Q/A · filed 2017-03-21 | 2.98M shares derived: sum of 3 quarters · filed 2017-03-21 | 3.48M shares derived: sum of 4 quarters · filed 2017-03-21 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-05 | 205.00K shares derived: sum of 2 quarters · filed 2016-05-05 | 700.00K shares derived: sum of 3 quarters · filed 2016-05-05 | 1.08M shares derived: sum of 4 quarters · filed 2016-05-05 |
| 2015-12-31 | 205.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 700.00K shares derived: sum of 2 quarters · filed 2016-03-30 | 1.08M shares derived: sum of 3 quarters · filed 2016-03-30 | 1.85M shares 10-K · filed 2016-03-30 |
| 2015-09-30 | 495.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 872.50K shares derived: sum of 2 quarters · filed 2015-11-12 | 1.64M shares 10-Q · filed 2015-11-12 | 1.99M shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | 377.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 1.15M shares 10-Q · filed 2015-08-06 | 1.49M shares derived: sum of 3 quarters · filed 2015-08-06 | 2.14M shares derived: sum of 4 quarters · filed 2015-08-06 |
| 2015-03-31 | 768.32K shares 10-Q · filed 2015-05-13 | 1.11M shares derived: sum of 2 quarters · filed 2015-05-13 | 1.76M shares derived: sum of 3 quarters · filed 2015-05-13 | 2.88M shares derived: sum of 4 quarters · filed 2015-05-13 |
| 2014-12-31 | 345.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | 990.00K shares derived: sum of 2 quarters · filed 2015-03-30 | 2.12M shares derived: sum of 3 quarters · filed 2015-03-30 | 2.43M shares 10-K · filed 2015-03-30 |
| 2014-09-30 | 645.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 1.77M shares derived: sum of 2 quarters · filed 2014-11-12 | 2.08M shares 10-Q · filed 2014-11-12 | 2.16M shares derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-06-30 | 1.13M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | 1.44M shares 10-Q · filed 2014-08-12 | 1.52M shares derived: sum of 3 quarters · filed 2014-08-12 | 1.64M shares derived: sum of 4 quarters · filed 2014-08-12 |
| 2014-03-31 | 311.67K shares 10-Q · filed 2014-05-14 | 393.86K shares derived: sum of 2 quarters · filed 2014-05-14 | 516.60K shares derived: sum of 3 quarters · filed 2014-05-14 | 1.22M shares derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-12-31 | 82.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | 204.93K shares derived: sum of 2 quarters · filed 2014-03-27 | 904.87K shares derived: sum of 3 quarters · filed 2014-03-27 | 1.51M shares 10-K · filed 2014-03-27 |
| 2013-09-30 | 122.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 822.68K shares derived: sum of 2 quarters · filed 2013-11-12 | 1.43M shares 10-Q · filed 2013-11-12 | 1.85M shares derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | 699.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 1.30M shares 10-Q · filed 2013-08-14 | 1.73M shares derived: sum of 3 quarters · filed 2013-08-14 | |
| 2013-03-31 | 602.71K shares 10-Q · filed 2013-05-15 | 1.03M shares derived: sum of 2 quarters · filed 2013-05-15 | ||
| 2012-12-31 | 428.00K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | 447.76K shares 10-K · filed 2013-03-28 | ||
| 2012-09-30 | 19.76K shares 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |